# POST URS Chemotherapy Instillation

> **NCT06167057** · NA · RECRUITING · sponsor: **Carmel Medical Center** · enrollment: 264 (estimated)

## Conditions studied

- UTUC

## Interventions

- **DRUG:** Mitomycin/Gemcitabine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06167057
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-17
- **Primary completion:** 2028-01-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06167057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06167057, "POST URS Chemotherapy Instillation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06167057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*